Physician profile
Deborah B Johnson
NPI 1255373288
$419.28
in general payments reported to CMS, 2019-2025
12 companies · $95.13 in 2025
The $95.13 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.42 · 2021: $27.66 · 2022: $12.56 · 2023: $134 · 2024: $138 · 2025: $95.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $367.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $143.63 | 2024-2025 | Wegovy |
| Irhythm Technologies, INC. | $54.35 | 2024 | Zio Monitor, Zio Xt Patch |
| Glaxosmithkline, LLC. | $39.73 | 2023-2024 | Shingrix |
| Abbott Laboratories | $38.88 | 2022-2023 | Freestyle Libre 2 |
| Gilead Sciences, INC. | $27.66 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.80 | 2023 | |
| Dexcom, INC. | $22.03 | 2023 | Dexcom G6 Transmitter |
| Axsome Therapeutics, INC. | $14.85 | 2024 | Auvelity |
| Exact Sciences Corporation | $14.71 | 2023 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $14.32 | 2023 | Gvoke Hypopen |
| Abbvie INC. | $13.90 | 2023 | |
| Ironshore Pharmaceuticals INC. | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.